L35M drug discovery center for Scotland

A L35.0 million ($69.7 million) drug discovery and development center to tackle the major diseases of the 21st Century is to be created at the University of Strathclyde in Glasgow, Scotland.

The Strathclyde Institute of Pharmacy and Biomedical Sciences will focus on priority health care issues from improving understanding of the immune system to new drugs to combat methicillin-resistant Staphylococcus aureus. A state-of-the-art building is now a step closer thanks to a L1.75 million grant from the Wolfson Foundation.

The new building will be constructed on Glasgow's Cathedral Street by 2010. The University has committed L27.0 million to the development and has launched a fundraising campaign for the remaining L8.0 million.